Search Within

Mikhail Roshal

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (18)
  2. Meeting Abstract (11)
  3. Research Letter (2)
  4. Correspondence (1)
Groups
  1. Department of Pathology and Laboratory Medicine (32)
  2. Population Sciences Research Program (32)
  3. Center for Hematologic Malignancies (31)
  4. Department of Medicine (31)
  5. Hematologic Malignancies, Division of (31)
  6. Epidemiology and Biostatistics (22)

More Groups

People
  1. Andriy Derkach (21)
  2. Ahmet Dogan (18)
  3. Wenbin Xiao (16)
  4. Maria Arcila (14)
  5. Qi Gao (13)
  6. Sergio Giralt (12)

More People

Years
  1. 2025 (2)
  2. 2024 (4)
  3. 2023 (6)
  4. 2022 (2)
  5. 2021 (7)
  6. 2020 (9)

More Years

Publications
  1. Blood (11)
  2. Blood Advances (4)
  3. American Journal of Hematology (2)
  4. Cytometry Part B—Clinical Cytometry (2)
  5. Haematologica (2)
  6. Leukemia and Lymphoma (2)

More Publications

Publishers
  1. American Society of Hematology (15)
  2. Wiley Blackwell (3)
  3. Ferrata Storti Foundation (2)
  4. John Wiley & Sons, Inc. (2)
  5. Nature Publishing Group (2)
  6. Taylor & Francis Group (2)

More Publishers

Results (32)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML
    Journal Article

    Stahl, M.; Menghrajani, K.; Derkach, A.; Chan, A.; Xiao, W.; Glass, J.; King, A. C.; Daniyan, A. F.; Famulare, C.; Cuello, B. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Venetoclax therapy for relapsed and treatment refractory AML: Clinical outcomes and molecular predictors
    Meeting Abstract

    Stahl, M.; Menghrajani, K.; Derkach, A.; Chan, A.; Xiao, W.; Glass, J. L.; King, A. C.; Daniyan, A.; Famulare, C.; Cuello, B. M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clinical outcomes of acute myeloid leukemia patients bridged to allogeneic stem cell transplant by venetoclax combination therapy
    Meeting Abstract

    Stahl, M.; Menghrajani, K.; Derkach, A.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; Barker, J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Molecular predictors and effectiveness of measurable residual disease (MRD) eradication with chemotherapy and allogeneic stem cell transplantation for acute myeloid leukemia
    Meeting Abstract

    Stahl, M.; Derkach, A.; Famulare, C.; Cho, C.; Devlin, S.; Farnoud, N.; Menghrajani, K.; Patel, M. A.; Cai, S. F.; Geyer, M. B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy in newly diagnosed multiple myeloma: final results from a clinical and correlative phase 2 study
    Meeting Abstract

    Landgren, O.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Diamond, B.; Salcedo, M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Long-term sustained minimal residual disease (MRD) negativity in patients with multiple myeloma treated with continuous lenalidomide maintenance therapy: A clinical and correlative phase 2 study
    Meeting Abstract

    Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U. A.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Venetoclax and hypomethylating agents (HMAs) induce high response rates in MDS, including patients after HMA therapy failure
    Journal Article

    Ball, B. J.; Famulare, C. A.; Stein, E. M.; Tallman, M. S.; Derkach, A.; Roshal, M.; Gill, S. I.; Manning, B. M.; Koprivnikar, J.; McCloskey, J.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms
    Journal Article

    Lewis, N. E.; Petrova-Drus, K.; Huet, S.; Epstein-Peterson, Z. D.; Gao, Q.; Sigler, A. E.; Baik, J.; Ozkaya, N.; Moskowitz, A. J.; Kumar, A.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Clonal hematopoiesis (CH) in angioimmunoblastic T-cell lymphoma (AITL) with divergent evolution to myeloid neoplasms (MNs)
    Meeting Abstract

    Lewis, N.; Petrova-Drus, K.; Epstein-Peterson, Z.; Huet, S.; Gao, Q.; Sigler, A.; Baik, J.; Kumar, A.; Horwitz, S.; Zhang, Y.; more...
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • Bright PD-1 expression by flow cytometry is a powerful tool for diagnosis and monitoring of angioimmunoblastic T-cell lymphoma
    Journal Article

    Yabe, M.; Gao, Q.; Ozkaya, N.; Huet, S.; Lewis, N.; Pichardo, J. D.; Moskowitz, A. J.; Horwitz, S. M.; Dogan, A.; Roshal, M.
    Blood Cancer Journal (2020)

    Fulltext@MSK | Save